Se Connecter/S’inscrire
Votre courriel a été envoyé.
Certaines informations ont été traduites automatiquement.
Faits saillants de l'investissement
- Single Tenant Net Lease Investment Opportunity
Résumé de l'annonce
Ciminelli is pleased to exclusively present the opportunity to acquire a free-standing, single-tenant dialysis facility leased to Fresenius Medical Care (“Fresenius”) with more than 10 years of remaining lease term.
Fresenius has operated at this location since April 2017 and recently executed a new 10-year lease extension commencing April 1, 2027 and expiring March 31, 2037, demonstrating the tenant’s long-term commitment to the site and the mission-critical nature of the facility.
The Property is offered with a modified net lease structure, providing investors with an attractive yield premium relative to traditional absolute net leased assets while maintaining the security of long-term occupancy by one of the world’s leading dialysis providers.
About the Tenant
Fresenius Medical Care (NYSE: FMS) is a global leader in dialysis services and products, operating approximately 3,675 clinics across more than 40 countries. Collectively, these facilities serve approximately 299,000 patients and provide nearly 48 million treatments annually. In the United States alone, Fresenius Kidney Care operates more than 2,200 dialysis centers serving approximately 200,000 patients, representing an estimated 37% share of the U.S. dialysis market.
Fresenius has operated at this location since April 2017 and recently executed a new 10-year lease extension commencing April 1, 2027 and expiring March 31, 2037, demonstrating the tenant’s long-term commitment to the site and the mission-critical nature of the facility.
The Property is offered with a modified net lease structure, providing investors with an attractive yield premium relative to traditional absolute net leased assets while maintaining the security of long-term occupancy by one of the world’s leading dialysis providers.
About the Tenant
Fresenius Medical Care (NYSE: FMS) is a global leader in dialysis services and products, operating approximately 3,675 clinics across more than 40 countries. Collectively, these facilities serve approximately 299,000 patients and provide nearly 48 million treatments annually. In the United States alone, Fresenius Kidney Care operates more than 2,200 dialysis centers serving approximately 200,000 patients, representing an estimated 37% share of the U.S. dialysis market.
Salle de données Cliquez ici pour accéder à
- Offering Memorandum
Faits sur la propriété
Type de vente
Investissement
Type de propriété
Bureau
Sous-type de propriété
Médical
Taille du bâtiment
3 806 pi²
Classe d’immeuble
B
Année de construction
1972
Prix
1 936 970 $ CAD
Prix par pi²
508,93 $ CAD
Location
Unique
Hauteur du bâtiment
1 étage
Superficie de plancher typique
3 806 pi²
Coefficient d’occupation des sols de l’immeuble
0,31
Taille du lot
0,28 AC
Zonage
C-2 - General Commercial & Services
Stationnement
10 places (2,63 places par 1 000 pi² loué)
1 1
Assez accessible à pied
50/100
Exceptionnellement adapté aux voitures
100/100
Transports en commun relativement accessibles
40/100
Moyennement accessible en vélo
60/100
Impôts fonciers
| Numéro de lot | 34-30-15-00000-240-0300 | Évaluation des bâtiments | 458 401 $ CAD |
| Évaluation du terrain | 274 881 $ CAD | Évaluation totale | 733 282 $ CAD |
Impôts fonciers
Numéro de lot
34-30-15-00000-240-0300
Évaluation du terrain
274 881 $ CAD
Évaluation des bâtiments
458 401 $ CAD
Évaluation totale
733 282 $ CAD
1 de 7
Vidéos
Visite extérieure 3D Matterport
Visite 3D Matterport
Photos
Vue depuis la rue
Rue
Carte
1 de 1
Présenté par
6450 Seminole Blvd
Vous êtes déjà membre? Connectez-vous
Hmm, il semble y avoir eu une erreur lors de l’envoi de votre message. Veuillez réessayer.
Merci! Votre message a été envoyé.



